ConductScience.org, home

Paper36964457

Clinical benefit of MAO-B and COMT inhibition in Parkinson's disease: practical considerations.

Regensburger M and 6 others. J Neural Transm (Vienna), 2023. Cited by 56 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Clinical benefit of MAO-B and COMT inhibition in Parkinson's disease: practical considerations. Papers, record 36964457. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36964457

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical benefit of MAO-B and COMT inhibition in Parkinson's disease: practical considerations.
PubMed
Journal
J Neural Transm (Vienna)
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
56
iCite
Relative citation ratio, by iCite
8.58
iCite
Revised in PubMed
2025-08-03
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Parkinson DiseaseMajor topic
Humans
Antiparkinson Agents
Monoamine Oxidase
Catechol O-Methyltransferase
Levodopa
Catechol O-Methyltransferase Inhibitors
Monoamine Oxidase Inhibitors

Source PubMed

References134

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115,551,331Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.Mov Disord2005https://conductscience.org/library/papers/15551331PubMed
29,305,320Tolcapone in stable Parkinson's disease: efficacy and safety of long-term treatment. The Tolcapone Stable Study Group.Neurology1997https://conductscience.org/library/papers/9305320PubMed
310,027,853Biochemical and electrophysiological studies on the mechanism of action of PNU-151774E, a novel antiepileptic compound.J Pharmacol Exp Ther1999https://conductscience.org/library/papers/10027853PubMed
412,470,183A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study.Arch Neurol2002https://conductscience.org/library/papers/12470183PubMed
530,673,543Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease.N Engl J Med2019https://conductscience.org/library/papers/30673543PubMed
629,971,495Levodopa-induced dyskinesia: clinical features, incidence, and risk factors.J Neural Transm (Vienna)2018https://conductscience.org/library/papers/29971495PubMed
724,756,517Pharmacological treatment of Parkinson disease: a review.JAMA2014https://conductscience.org/library/papers/24756517PubMed
836,346,534
The XINDI Study: A Randomized Phase III Clinical Trial Evaluating the Efficacy and Safety of Safinamide as Add-On Therapy to Levodopa in Chinese Patients with Parkinson's Disease with Motor Fluctuations.
CNS Drugs2022https://conductscience.org/library/papers/36346534PubMed
926,817,533Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients.Mov Disord2016https://conductscience.org/library/papers/26817533PubMed
1035,705,887Opicapone as an Add-on to Levodopa in Patients with Parkinson's Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial.Neurol Ther2022https://conductscience.org/library/papers/35705887PubMed
1110,803,796A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia.Clin Neuropharmacol2000https://conductscience.org/library/papers/10803796PubMed
128,988,465Pharmacology and neuroprotective properties of rasagiline.J Neural Transm Suppl1996https://conductscience.org/library/papers/8988465PubMed
1332,446,176Efficacy and safety of safinamide as an add-on therapy to L-DOPA for patients with Parkinson's disease: A randomized, double-blind, placebo-controlled, phase II/III study.Parkinsonism Relat Disord2020https://conductscience.org/library/papers/32446176PubMed
1415,590,952Levodopa and the progression of Parkinson's disease.N Engl J Med2004https://conductscience.org/library/papers/15590952PubMed
1522,136,163Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial.Eur J Neurol2012https://conductscience.org/library/papers/22136163PubMed
1615,096,406A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease.Arch Neurol2004https://conductscience.org/library/papers/15096406PubMed
1734,554,335Safinamide improves sleep and daytime sleepiness in Parkinson's disease: results from the SAFINONMOTOR study.Neurol Sci2022https://conductscience.org/library/papers/34554335PubMed
1829,167,350Safinamide Differentially Modulates In Vivo Glutamate and GABA Release in the Rat Hippocampus and Basal Ganglia.J Pharmacol Exp Ther2018https://conductscience.org/library/papers/29167350PubMed
1912,211,134Management of Parkinson's disease: an evidence-based review.Mov Disord2002https://conductscience.org/library/papers/12211134PubMed
2028,523,235Effects of levodopa/carbidopa intestinal gel versus oral levodopa/carbidopa on B vitamin levels and neuropathy.Brain Behav2017https://conductscience.org/library/papers/28523235PubMed

See all 134 references

Cited by44

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.

PMIDTitleJournalYearIn PapersSource
42,974,025Effects of eating behavior patterns and dietary habits on the therapeutic efficacy of Parkinson's disease medications: from phenomena, mechanisms to clinical applications.Front Nutr2026https://conductscience.org/library/papers/42974025PubMed
42,829,398The safety and tolerability of opicapone in elderly Parkinson's disease patients: a real-world, multicenter, retrospective study.J Neural Transm (Vienna)2026https://conductscience.org/library/papers/42829398PubMed
42,730,819German Delphi consensus: COMT inhibitors in the management of wearing-off fluctuations in Parkinson's disease.J Neural Transm (Vienna)2026https://conductscience.org/library/papers/42730819PubMed
42,679,808Carotid body dysfunction contributes to respiratory instability in Rett syndrome.Curr Biol2026https://conductscience.org/library/papers/42679808PubMed
42,575,718Rational Design of Multifunctional Tacrine Derivatives as Candidates for the Treatment of Alzheimer and Parkinson Diseases.ChemMedChem2026https://conductscience.org/library/papers/42575718PubMed
42,558,392
Neuroprotective role of Lactiplantibacillus plantarum C10-derived SCFAs: a functional food approach targeting gut-brain-axis disruption in rotenone-induced Parkinson's disease in-vivo in adult zebrafish.
Front Nutr2026https://conductscience.org/library/papers/42558392PubMed
42,356,373
Curcumin, Coenzyme-Q10, and Bioactive Compounds in Ashwagandha Extract: Multi-Targeting Potential of Co-Administered Natural Health Compounds as Therapeutic and Preventative Interventions in Alzheimer's and Parkinson's Disease Models.
Nutrients2026https://conductscience.org/library/papers/42356373PubMed
42,252,551The Use of Statins in Parkinson's and Alzheimer's Disease: A 2021-2025 State-of-the-Art Review of Clinical and Preclinical Evidence.Pharmacol Res Perspect2026https://conductscience.org/library/papers/42252551PubMed
42,016,531Opicapone in Parkinson's patients with motor fluctuations: clinical assessments and patient-reported outcomes from the OPTI-ON study.Clin Park Relat Disord2026https://conductscience.org/library/papers/42016531PubMed
41,949,708Parkinson's disease: pathogenesis and therapeutic strategies.Mol Biomed2026https://conductscience.org/library/papers/41949708PubMed
41,782,314Advanced Parkinson's disease treatment patterns in Italy: results from a multicenter observational study.Ann Med2026https://conductscience.org/library/papers/41782314PubMed
41,716,552Efficacy of MAO-B and COMT inhibitors on quality of life in patients with Parkinson's disease: a Bayesian network meta-analysis.Front Neurol2026https://conductscience.org/library/papers/41716552PubMed
41,646,181Molecular mechanisms of exercise-induced neuroprotection against Parkinson's disease.Sports Med Health Sci2026https://conductscience.org/library/papers/41646181PubMed
41,516,245Neuroprotective and Antioxidant Activity of Newly Synthesized N-Pyrrolyl Hydrazide-Hydrazones in Experimental Models of Neurotoxicity In Vitro and In Vivo.Int J Mol Sci2025https://conductscience.org/library/papers/41516245PubMed
41,471,556Microwave Imaging for Parkinson's Disease Detection: A Phantom-Based Feasibility Study Using Temperature-Controlled Dielectric Variations.Sensors (Basel)2025https://conductscience.org/library/papers/41471556PubMed
41,471,108Sialic Acid in Neurodegenerative and Psychiatric Disorders: From Molecular Regulation to Targeted Nanocarrier-Based Therapy.Pharmaceutics2025https://conductscience.org/library/papers/41471108PubMed
41,465,423The Effect of Dopaminergic Therapies in Parkinson's Disease on Non-Motor Symptoms.Int J Mol Sci2025https://conductscience.org/library/papers/41465423PubMed
41,304,978Catharanthus roseus Phytochemicals as Multi-Target Modulators of Disability-Linked Neurodegeneration: Bio-Computational Insights.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41304978PubMed
41,276,723Neuroprotective Attributes of Gut-derived Urolithins in Parkinson's Disease.Mol Neurobiol2025https://conductscience.org/library/papers/41276723PubMed
41,204,267Biomimetic nanodelivery system with simultaneous blood-brain barrier-crossing and neuroprotective abilities for anti-parkinsonian therapy.Chin Med2025https://conductscience.org/library/papers/41204267PubMed

See all 44 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
COMT1,312PubTator's text mininghttps://conductscience.org/library/genes/1312NCBI Gene
MAOB4,129PubTator's text mininghttps://conductscience.org/library/genes/4129NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36964457

GET https://conductscience.org/api/papers/v1/36964457/references?page=2